References
- American Cancer SocietyCancer Facts and Figures 2016Atlanta, GAAmerican Cancer Society, Inc2016 Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdfAccessed October 14, 2016
- American Cancer SocietyBreast Cancer Facts and Figures 2015–2016Atlanta, GAAmerican Cancer Society Inc2015
- HowladerNNooneAMKrapchoMSEER Cancer Statistics Review, 1975–2013Bethesda, MDNational Cancer Institute Available from: https://seer.cancer.gov/archive/csr/1975_2014/#contents. Updated September 12, 2016Accessed August 29, 2017
- PolyakKHeterogeneity in breast cancerJ Clin Invest2011121103786378821965334
- LobbezooDJvan KampenRJVoogdACPrognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeBreast Cancer Res Treat2013141350751424104881
- NCCN Clinical Practice Guidelines in OncologyBreast Cancer. V22017 Available from: https://www.nccn.org/professionals/physician_gls/PDF/breast.pdfAccessed March 6, 2017
- Abraxane [package insert]Summit, NJCelgene Corporation2015
- Taxol [package insert]North Wales, PATeva Parenteral Medicines, Inc2015
- GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
- HershmanDLWrightJDComparative effectiveness research in oncology methodology: observational dataJ Clin Oncol201230344215422223071228
- ShermanREAndersonSADal PanGJReal-world evidence— what is it and what can it tell us?N Engl J Med2016375232293229727959688
- ArikianSRMilentijevicDBinderGPatterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myelomaCurr Med Res Opin20153161105111525785551
- ChenCCParikhKAbouzaidSReal-world treatment patterns, time to next treatment, and economic outcomes in relapsed or refractory multiple myeloma patients treated with pomalidomide or carfilzomibJ Manag Care Spec Pharm201723223624628125372
- WeissRBDonehowerRCWiernikPHHypersensitivity reactions from taxolJ Clin Oncol199087126312681972736
- PalumboRSottotettiFTrifiroGNanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of lifeDrug Des Devel Ther2015921892199
- Forero-TorresAVarleyKAbramsonVTBCRC 019: a Phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancerClin Cancer Res201521122722272925779953